Identification and Characterization of an Intergenic "Safe Haven" Region in Human Fungal Pathogen Cryptococcus gattii
- PMID: 35205930
- PMCID: PMC8874978
- DOI: 10.3390/jof8020178
Identification and Characterization of an Intergenic "Safe Haven" Region in Human Fungal Pathogen Cryptococcus gattii
Abstract
Cryptococcus gattii is a primary fungal pathogen, which causes pulmonary and brain infections in healthy as well as immunocompromised individuals. Genetic manipulations in this pathogen are widely employed to study its biology and pathogenesis, and require integration of foreign DNA into the genome. Thus, identification of gene free regions where integrated foreign DNA can be expressed without influencing, or being influenced by, nearby genes would be extremely valuable. To achieve this goal, we examined publicly available genomes and transcriptomes of C. gattii, and identified two intergenic regions in the reference strain R265 as potential "safe haven" regions, named as CgSH1 and CgSH2. We found that insertion of a fluorescent reporter gene and a selection marker at these two intergenic regions did not affect the expression of their neighboring genes and were also expressed efficiently, as expected. Furthermore, DNA integration at CgSH1 or CgSH2 had no apparent effect on the growth of C. gattii, its response to various stresses, or phagocytosis by macrophages. Thus, the identified safe haven regions in C. gattii provide an effective tool for researchers to reduce variation and increase reproducibility in genetic experiments.
Keywords: Cryptococcus gattii; complementation; ectopic integration; genome editing; safe haven.
Conflict of interest statement
The authors declare no competing interest.
Figures
Similar articles
-
An intergenic "safe haven" region in Cryptococcus neoformans serotype D genomes.Fungal Genet Biol. 2020 Nov;144:103464. doi: 10.1016/j.fgb.2020.103464. Epub 2020 Sep 15. Fungal Genet Biol. 2020. PMID: 32947034 Free PMC article.
-
Chitosan Biosynthesis and Virulence in the Human Fungal Pathogen Cryptococcus gattii.mSphere. 2019 Oct 9;4(5):e00644-19. doi: 10.1128/mSphere.00644-19. mSphere. 2019. PMID: 31597720 Free PMC article.
-
A fluorogenic C. neoformans reporter strain with a robust expression of m-cherry expressed from a safe haven site in the genome.Fungal Genet Biol. 2017 Nov;108:13-25. doi: 10.1016/j.fgb.2017.08.008. Epub 2017 Sep 12. Fungal Genet Biol. 2017. PMID: 28870457 Free PMC article.
-
Cryptococcus gattii comparative genomics and transcriptomics: a NIH/NIAID White Paper.Mycopathologia. 2012 Jun;173(5-6):367-73. doi: 10.1007/s11046-011-9512-9. Epub 2011 Dec 17. Mycopathologia. 2012. PMID: 22179781 Review.
-
Cryptococcus gattii: a resurgent fungal pathogen.Trends Microbiol. 2011 Nov;19(11):564-71. doi: 10.1016/j.tim.2011.07.010. Epub 2011 Aug 29. Trends Microbiol. 2011. PMID: 21880492 Free PMC article. Review.
Cited by
-
Illuminating the Cryptococcus neoformans species complex: unveiling intracellular structures with fluorescent-protein-based markers.Genetics. 2024 Jul 8;227(3):iyae059. doi: 10.1093/genetics/iyae059. Genetics. 2024. PMID: 38752295
-
Aspartyl peptidase May1 induces host inflammatory response by altering cell wall composition in the fungal pathogen Cryptococcus neoformans.mBio. 2024 Jun 12;15(6):e0092024. doi: 10.1128/mbio.00920-24. Epub 2024 May 14. mBio. 2024. PMID: 38742885 Free PMC article.
References
-
- Rajasingham R., Smith R.M., Park B.J., Jarvis J.N., Govender N.P., Chiller T.M., Denning D.W., Loyse A., Boulware D.R. Global burden of disease of HIV-associated cryptococcal meningitis: An updated analysis. Lancet Infect. Dis. 2017;17:873–881. doi: 10.1016/S1473-3099(17)30243-8. - DOI - PMC - PubMed
-
- Casadevall A., Perfect J.R. Cryptococcus neoformans. ASM Press; Washington, DC, USA: 1998.
Grants and funding
LinkOut - more resources
Full Text Sources